期刊
PHARMACEUTICS
卷 14, 期 8, 页码 -出版社
MDPI
DOI: 10.3390/pharmaceutics14081599
关键词
antifibrotic strategies; cardiac fibrosis; cardiovascular diseases; fibrosis pathways; therapeutic strategies
资金
- Romanian Ministry of Education and Research, CNCS-UEFISCDI within PNCDI III [PN-III-P1-1.1-TE-2019-0370]
This paper provides a comprehensive review of cardiac fibrosis, including its pathophysiological pathways, its role in cardiovascular diseases, and potential therapeutic strategies. It also highlights unanswered questions and identifies areas for future research.
Fibrosis, characterized by an excessive accumulation of extracellular matrix, has long been seen as an adaptive process that contributes to tissue healing and regeneration. More recently, however, cardiac fibrosis has been shown to be a central element in many cardiovascular diseases (CVDs), contributing to the alteration of cardiac electrical and mechanical functions in a wide range of clinical settings. This paper aims to provide a comprehensive review of cardiac fibrosis, with a focus on the main pathophysiological pathways involved in its onset and progression, its role in various cardiovascular conditions, and on the potential of currently available and emerging therapeutic strategies to counteract the development and/or progression of fibrosis in CVDs. We also emphasize a number of questions that remain to be answered, and we identify hotspots for future research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据